Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 16

Results For "Drug-Development"

219 News Found

ScienceMedia and Apex Mobile Clinical Research sign partnership for clinical trial training
Biotech | March 27, 2022

ScienceMedia and Apex Mobile Clinical Research sign partnership for clinical trial training

The implementation of ScienceMedia's solutions will ultimately help AMCR collapse patient recruitment and enrollment


Insilico Medicine and EQRx to jointly advance AI-driven drug discovery
Biotech | March 24, 2022

Insilico Medicine and EQRx to jointly advance AI-driven drug discovery

The collaboration leverages Insilico's end-to-end AI-driven Pharma.AI platform to discover novel small molecule drug candidates for multiple targets, along with EQRx's innovative business model to accelerate drug development and patient access to novel medicines at affordable prices


Totus Medicines partners with Mila on a mission to treat the untreatable
Biotech | March 24, 2022

Totus Medicines partners with Mila on a mission to treat the untreatable

Organizations to combine expertise to further develop AI/ML-powered drug design platform, delivering precise, effective, and life-changing medicines at scale


Orgenics to conduct toxicology study on its intransal COVID-19 vaccine candidate
Biotech | March 23, 2022

Orgenics to conduct toxicology study on its intransal COVID-19 vaccine candidate

Data to establish the safety profile and human dose of vaccine candidate


Bristol Myers Squibb to demonstrate growing cardiovascular portfolio
Biotech | March 22, 2022

Bristol Myers Squibb to demonstrate growing cardiovascular portfolio

New data, including two late-breaking clinical trial presentations on mavacamten and a new analysis of the GUARD-AF study, reinforce the company’s continued commitment to those living with cardiovascular disease


Thermo Fisher Scientific to showcase global innovation at DCAT Week 2022
Medical Device | March 22, 2022

Thermo Fisher Scientific to showcase global innovation at DCAT Week 2022

Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers


USFDA approves Opdualag to treat metastatic melanoma
Drug Approval | March 19, 2022

USFDA approves Opdualag to treat metastatic melanoma

Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the PD-1 inhibitor nivolumab and novel LAG-3-blocking antibody relatlimab


Clarivate deals report highlights emerging trends in biopharma deal-making
Biotech | March 14, 2022

Clarivate deals report highlights emerging trends in biopharma deal-making

RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape


Emmes acquires Casimir, its fourth major acquisition
Biotech | March 11, 2022

Emmes acquires Casimir, its fourth major acquisition

Casimir further differentiates Emmes’ industry-leading rare disease research capabilities


Molecular Health and researchers prove new approach to anticipate molecular causation
Biotech | March 10, 2022

Molecular Health and researchers prove new approach to anticipate molecular causation

The studies demonstrate a standardized strategy to extend mechanistic modeling and systems pharmacology into drug safety and mode of action assessments that has relevance for drug development and a variety of other contexts